1,208
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue

, , &
Pages 2355-2362 | Received 17 Sep 2014, Accepted 10 Nov 2014, Published online: 23 Dec 2014

Figures & data

Figure 1. Amount of l-DOPA formed by hydrolysis of LDME versus time in buffered solutions at pH 7.4 (▴), pH 6.8

pH 6.5 (♦), pH 6.2 (▾), pH 6.0 (•) and pH 5.8 (▪) at 37 ± 0.2 °C. Data are presented as mean ± SD (n = 6).

Figure 1. Amount of l-DOPA formed by hydrolysis of LDME versus time in buffered solutions at pH 7.4 (▴), pH 6.8 Display full size pH 6.5 (♦), pH 6.2 (▾), pH 6.0 (•) and pH 5.8 (▪) at 37 ± 0.2 °C. Data are presented as mean ± SD (n = 6).

Table 1. Hydrolysis of LDME in absence and in presence of mucosal tissue after six hours of experiments (n = 6).

Figure 2. Cumulative amount of l-DOPA that reaches the receptor phase versus time following delivery of LDME solution (50 mg/mL, 37 ± 0.2 °C) at pH 5.8 (•) and pH 6.2 (▪). Values are presented as mean ± SD (n = 6).

Figure 2. Cumulative amount of l-DOPA that reaches the receptor phase versus time following delivery of LDME solution (50 mg/mL, 37 ± 0.2 °C) at pH 5.8 (•) and pH 6.2 (▪). Values are presented as mean ± SD (n = 6).

Figure 3. l-DOPA formed in absence (chemical hydrolysis) and in presence (cumulative: chemical plus enzymatic hydrolysis) of mucosal tissue versus time following delivery of LDME solution (50 mg/mL, 37 ± 0.2 °C) at: pH 5.8 chemical (♦); pH 5.8 cumulative (▾); pH 6.2 chemical (▪); and pH 6.2 cumulative (•). Values are presented as mean ± SD (n = 6).

Figure 3. l-DOPA formed in absence (chemical hydrolysis) and in presence (cumulative: chemical plus enzymatic hydrolysis) of mucosal tissue versus time following delivery of LDME solution (50 mg/mL, 37 ± 0.2 °C) at: pH 5.8 chemical (♦); pH 5.8 cumulative (▾); pH 6.2 chemical (▪); and pH 6.2 cumulative (•). Values are presented as mean ± SD (n = 6).

Figure 4. Cumulative amount of drug that reaches the acceptor compartment versus time following delivery of l-DOPA solution (1.5 mg/mL, 37 ± 0.2 °C) at pH 5.8 (♦) and pH 6.2 (▾). Values are presented as mean ± SD (n = 6).

Figure 4. Cumulative amount of drug that reaches the acceptor compartment versus time following delivery of l-DOPA solution (1.5 mg/mL, 37 ± 0.2 °C) at pH 5.8 (♦) and pH 6.2 (▾). Values are presented as mean ± SD (n = 6).

Figure 5. Cumulative amounts of l-DOPA in the acceptor compartment versus time: (a) following delivery of LDME at pH 6.2 in absence of enhancer (•) and in the presence of 1% (▪) and 2% (♦) of Tween 80®. (b) Following delivery of l-DOPA in absence of enhancer (○) and in the presence of 1% (□) and 2% (⋄) of Tween 80®. Values are presented as mean ± SD (n = 6).

Figure 5. Cumulative amounts of l-DOPA in the acceptor compartment versus time: (a) following delivery of LDME at pH 6.2 in absence of enhancer (•) and in the presence of 1% (▪) and 2% (♦) of Tween 80®. (b) Following delivery of l-DOPA in absence of enhancer (○) and in the presence of 1% (□) and 2% (⋄) of Tween 80®. Values are presented as mean ± SD (n = 6).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.